Package 0310-4500-12

{"route": ["INTRAVENOUS"], "spl_id": "686baf25-364f-4124-858f-151f1dae3756", "openfda": {"nui": ["N0000193338", "N0000193337", "N0000193336", "M0001357"], "unii": ["28X28X9OKV"], "rxcui": ["1919507", "1919512", "1919515", "1919516"], "spl_set_id": ["8baba4ea-2855-42fa-9bd9-5a7548d4cec3"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Programmed Death Ligand-1 Blocker [EPC]"], "pharm_class_moa": ["Programmed Death Ligand-1 Antagonists [MoA]", "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0310-4500-12)  / 2.4 mL in 1 VIAL", "package_ndc": "0310-4500-12", "marketing_start_date": "20170501"}], "brand_name": "IMFINZI", "product_id": "0310-4500_686baf25-364f-4124-858f-151f1dae3756", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Programmed Death Ligand-1 Antagonists [MoA]", "Programmed Death Ligand-1 Blocker [EPC]", "Programmed Death Ligand-1-directed Antibody Interactions [MoA]"], "product_ndc": "0310-4500", "generic_name": "Durvalumab", "labeler_name": "AstraZeneca Pharmaceuticals LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "IMFINZI", "active_ingredients": [{"name": "DURVALUMAB", "strength": "120 mg/2.4mL"}], "application_number": "BLA761069", "marketing_category": "BLA", "marketing_start_date": "20170501", "listing_expiration_date": "20261231"}